Active Ingredient: MELOXICAM
Proprietary Name: ANJESO
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N210583
Product Number: 001
Approval Date: Feb 20, 2020
Applicant Holder Full Name: BAUDAX BIO INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
